Clinical Sentinel Surveillance of Equine West Nile Fever, Spain.

This research investigates the use of clinical surveillance in horses to better detect and respond to West Nile fever (WNF), a viral infection spread by mosquitoes. The study, conducted in Spain from September 2010 to December 2011, found that specific clinical signs in horses, coupled with the time of year, can help distinguish between WNF and other disorders. This could provide an early warning system for potential human outbreaks.

Objectives of the Study

• The primary goal of the research was to enhance the early clinical detection of West Nile fever (WNF) in horses. By identifying clear clinical indicators, the study sought to distinguish WNF from other diseases, thereby providing an effective warning system for potential human WNF outbreaks.
• The research was also aimed at revealing the most cost-effective surveillance system to oversee WNF in a European context, which the study found to be passive surveillance by equine veterinarians.

Methodology

• The researchers utilized clinical data from a passive epidemiosurveillance network, obtained over a period stretching from September 2010 to December 2011.
• This data was analysed statistically, with the aim of developing a predictive diagnostic decision tree to aid in the early detection of WNF in horses.

Results of the Study

• The study found that while the clinical presentations of WNF in horses varied, four specific symptoms alongside the month of occurrence could act as useful indicators to differentiate between WNF-related and unrelated cases.
• The four symptoms included cranial nerve deficits, limb paralysis, photophobia (light sensitivity), and nasal discharge.

Implications of the Study

• Examining horses displaying neurological signs who have not been vaccinated against WNF could provide essential clues for early WNF detection, potentially serving as a warning for human viral infections.
• Understanding the clinical pattern of WNF in horses is vital in increasing awareness, comprehension, and enhancing surveillance designs for early clinical detection of WNF, potentially before it has a chance to affect human populations.